A Study to Investigate Leramistat in Patients With IPF

Stopped Due to slow initial recruitment and a lack of confidence in our ability to complete recruitment within the forecasted timeframe.

Conditions

• Idiopathic Pulmonary Fibrosis

Interventions

• DRUG: Leramistat
• DRUG: Placebo

Sponsor

Modern Biosciences Ltd